Meta-analysis of 58 randomized controlled trials (Lehrer et al. 2020, Applied Psychophysiology and Biofeedback): HRV biofeedback improves emotional and physical health and performance, with strongest effects on anxiety, depression and athletic performance.
This meta-analysis by Lehrer et al. (2020), published in Applied Psychophysiology and Biofeedback (PMID 32385728), analyzes 24 scientific trials conducted between 2010 and 2021 on the efficacy of heart rate variability biofeedback (HRV biofeedback) for reducing stress and anxiety in varied populations.
HRV biofeedback is a technique in which the patient learns to regulate breathing at a precise frequency (generally 0.1 Hz, or 6 breaths/minute) to maximize heart rate variability, a direct indicator of sympathovagal balance and resilience to stress.
The meta-analysis includes diverse populations: professionals under chronic stress, patients with generalized anxiety disorder, athletes, students and patients with stress-dependent somatic conditions.
Systematic search in PubMed, PsycINFO, Cochrane Library. 1 868 publications initially identified, filtered according to eligibility criteria to a final inclusion of 58 randomized controlled trials meeting methodological standards.
Studies retained: explicitly defined HRV biofeedback interventions, adult populations (clinical or non-clinical), active or waitlist control group, quantified pre-post measures, randomized controlled design with described randomization.
Anxiety, depression, anger, athletic and artistic performance, PTSD, sleep disorders, quality of life, chronic pain, hypertension. Effects analyzed short-term (immediate post-intervention) and medium-term (1-6 month follow-up).
Effect size calculations (Hedges' g, Cohen's d) by clinical domain. Random-effects meta-analysis. Heterogeneity assessment (I²), sensitivity analyses, publication bias evaluation via funnel plots and Egger's test.
An effect size of g = 0.81 on the reduction of perceived stress is scientifically exceptional. For comparison, first-line anxiolytics (benzodiazepines) show similar effect sizes on acute anxiety, but with major risks of tolerance and dependence. HRV biofeedback offers a comparable effect, without side effects and with transferable learning.
What is fundamental in our practice is that HRV biofeedback does not mask stress, it trains the autonomic nervous system to regulate the stress response more effectively. Our patients learn a physiological skill that belongs to them: they can activate cardiac coherence at will, in 90 seconds, without any equipment once training is complete.
The reduction of -14 mmHg in systolic blood pressure in hypertensive subgroups opens an important scientific application for patients with cardiovascular risk, as a complement or preventive to drug treatment.
Our HRV biofeedback sessions last 30 to 40 minutes and include real-time visual feedback of cardiac coherence, learning of breathing at a personalized resonance frequency, and progress monitoring through continuous RMSSD tracking.